Education
About Us
Working with TipRanks
Follow Us
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -8.02M | $ -8.53M | $ -7.05M | $ -2.15M | $ -67.63K |
| EBITDA | $ -8.02M | $ -8.53M | $ 0.00 | $ 0.00 | $ -67.63K |
| Net Income | $ -7.85M | $ -11.98M | $ -7.06M | $ -2.18M | $ -67.99K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.83M | $ 4.60M | $ 350.98K | $ 2.81M | $ 3.49K |
| Total Assets | $ 2.92M | $ 4.93M | $ 858.07K | $ 3.36M | $ 22.37K |
| Total Debt | $ 0.00 | $ 5.06K | $ 491.23K | $ 293.06K | $ 90.00K |
| Net Debt | $ -2.83M | $ -4.60M | $ 140.25K | $ -2.52M | $ 86.51K |
| Total Liabilities | $ 723.35K | $ 558.10K | $ 1.45M | $ 1.09M | $ 90.36K |
| Stockholders' Equity | $ 2.20M | $ 4.37M | $ -596.23K | $ 2.26M | $ -67.99K |
| Cash Flow | |||||
| Free Cash Flow | $ -5.56M | $ -4.53M | $ -5.60M | $ -1.38M | $ -67.99K |
| Operating Cash Flow | $ -5.56M | $ -4.53M | $ -5.60M | $ -1.38M | $ -67.99K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 3.79M | $ 8.78M | $ 3.15M | $ 4.18M | $ 71.12K |
MIRA Pharmaceuticals, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.